PR Newswire

Cision is a leading global provider of earned media software. Cision PR Newswire empowers communicators to identify influencers, craft campaigns and attribute value from the broadest spectrum of media sources, allowing them to create meaningful stories and measure the impact.
Results: 20857-20868 of 20878

Zuberitamab (Anruixi®), the first domestically developed anti-CD20 antibody as a Class I innovative drug from BioRay Pharmaceutical, has been approved for marketing in China

AI TECHNOLOGY COMES TO PROPERTY VALUATIONS HOMEMOVE LAUNCHES "HOMER" AI TOOL TO FIND OUT WHAT HOUSES ARE REALLY WORTH

Sagard expands its global footprint, opens its first office in the Gulf region and welcomes regional leader
